SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending due to a recently announced $5.5 billion, 15-year lease agreement with Amazon Web Services for AI workloads, sparking excitement about its shift towards AI infrastructure. The community is actively discussing the implications of this deal, potential price targets, and the company's strategic position in the AI data center space. Broader discussions include comparing deals between competitors like IREN, speculation around short squeezes, and overall sentiment on Cipher Mining's future prospects in a rapidly expanding sector.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies behind this OG meme coin.  community emphasizes its strong belief in the project and its potential to bring back the vibes of 2021. Talk centers on community building, conviction, and the expectation of a significant move, with many declaring "there is no chart."

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending due to a recently announced multi-year GPU cloud services contract with Microsoft valued at nearly $9.7 billion, sparking community excitement. The deal includes access to NVIDIA GB300 GPUs and a significant prepayment, solidifying IREN's position in the AI infrastructure space. Bullish investors anticipate further upside, while some debate the deal's value and the company's future earnings potential ahead of its upcoming earnings report.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is trending as investors discuss recent earnings and future growth prospects, especially the potential of Briumvi and the upcoming subq formulation. The community is split between those pushing for a buyout and those who believe in the company's long-term potential as an independent entity. Discussions also revolve around share buybacks and the impact of market dynamics on the stock's performance.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

MTEX is trending due to discussions around its low float and potential for a significant rally, with traders actively monitoring key breakout levels. The community is debating whether the stock will break resistance and experience a large upward move, or if it's a pump and dump scheme. Many are drawing comparisons to other low-float stocks that have recently seen parabolic runs.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending following news of a major partnership with OpenAI, sparking optimism about the future of AWS and its AI capabilities. Bullish sentiment is fueled by discussions around AWS's potential for growth and the impact of AI on Amazon's overall business strategy, though some community members are wary of a potential bubble. Some traders are discussing the possibility of short-term pullbacks following the earnings pop.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue ($KVUE) is trending amid discussions around a potential buyout offer, with community members debating fair value and buyout price. Speculation abounds regarding the deal's implications for Kenvue and parent company Kimberly-Clark ($KMB). Bullish sentiment is fueled by perceived overreactions to lawsuits and strong brand recognition.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure ($QURE) is trending due to an unexpected shift in the FDA's stance on their Huntington's disease therapy, AMT-130, leading to uncertainty around its BLA submission. The community is debating the implications of the FDA's decision, potential delays, and the path forward for the treatment while some question the current valuation. Some traders believe a buyout is coming.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to a lawsuit filed against a former FDA official for alleged bribery and defamation, sparking community discussion around stock manipulation and potential repercussions. The lawsuit coincides with upcoming earnings, adding to the stock's volatility as investors debate the impact of both events. Broader discussions include the company's future prospects, potential for a buyout, and concerns about management effectiveness.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Terns Pharmaceuticals Inc

TERN is trending due to positive clinical data for its TERN-701 candidate in heavily pretreated CML patients, which will be presented at an upcoming medical conference. The community is praising the data and contrasting TERN's transparency with other companies in the sector, like ALT. Some investors believe TERN's CML asset positions it as a potential acquisition target.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


camnangsuckhoe

camnangsuckhoe